Início › Mieloma Múltiplo › Pensilvânia › Philadelphia
Ensaios clínicos de Mieloma Múltiplo em Philadelphia, PA
16 estudos para Mieloma Múltiplo estão buscando participantes em locais em Philadelphia e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
RecrutandoFase 1
- University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine, Philadelphia
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
RecrutandoFase 3
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
RecrutandoFase 4
- University of Pennsylvania, Philadelphia
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
RecrutandoFase 1/2
- Penn Medicine, Philadelphia
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecrutandoFase 2
- Fox Chase Cancer Center, Philadelphia
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
RecrutandoFase 2
- Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
RecrutandoFase 1/2
- Research Site, Philadelphia
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RecrutandoFase 3
- Thomas Jefferson University Hospital, Philadelphia
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
RecrutandoFase 1
- University of Pennsylvania, Philadelphia
Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment
RecrutandoFase 1/2
- ECOG-ACRIN Cancer Research Group, Philadelphia
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
RecrutandoFase 1/2
- Penn Medicine - Abramson Cancer Center Perelman, Philadelphia
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Recrutando
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
RecrutandoFase 3
- Abramson Cancer Center University of Pennsylvania Medical Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RecrutandoFase 1/2
- Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Mozobil for Autologous Hematopoietic Stem Cell Transplantation
RecrutandoFase 2
- Thomas Jefferson University Hospital, Philadelphia
Limited-duration Teclistamab
RecrutandoFase 2
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
Ensaios de Mieloma Múltiplo em outras cidades
- New York City, NY60 estudos
- Boston, MA42 estudos
- Atlanta, GA41 estudos
- Houston, TX38 estudos
- Durham, NC37 estudos
- Nashville, TN32 estudos
- Denver, CO27 estudos
- Rochester, MN24 estudos
- St. Louis, MO24 estudos
- Columbus, OH24 estudos
- Baldwin Park, CA23 estudos
- Chicago, IL22 estudos
Outros estudos em Philadelphia
- Câncer (todos os tipos)59 estudos
- Câncer de Mama56 estudos
- Câncer de Pulmão de Não Pequenas Células51 estudos
- Câncer Metastático46 estudos
- Câncer Colorretal44 estudos
- Câncer de Ovário44 estudos
- Câncer de Próstata44 estudos
- Câncer de Pulmão36 estudos
- Leucemia Mieloide Aguda34 estudos
- Insuficiência Cardíaca31 estudos
- Câncer Endometrial28 estudos
- Depressão26 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.